Recommendations for the use of rotavirus vaccines in infants

Paediatrics and Child Health

Volumn 15, Issue 8, 2010, Pages 519-523

  Bortolussi, Robert ^a   Finlay, Jane ^b   McDonald, Jane C ^c   Onyett, Heather ^d   Robinson, Joan L ^b   Rousseau Harsany, Élisabeth ^e   Allen, Upton D ^f   Hui, Charles P S ^g   Pickering, Larry ^b   Kellner, James ^b   MacDonald, Noni E ^a   Moore, Dorothy L ^c   Salvadori, Marina I ^h   Le Saux, Nicole ^g  

^a IWK HEALTH CENTRE   (Canada)

^b Montreal Children's Hospital ^*

^c MONTREAL CHILDREN S HOSPITAL   (Canada)

^d KINGSTON GENERAL HOSPITAL   (Canada)

^e UNIVERSITY OF MONTREAL   (Canada)

^f HOSPITAL FOR SICK CHILDREN   (Canada)

^g CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^h CHILDREN S HOSPITAL OF WESTERN ONTARIO   (Canada)

Author keywords

Acute gastroenteritis; Children; Diarrhea; Oral vaccine; Rotavirus; Vaccine

Indexed keywords

ROTAVIRUS VACCINE;

ARTICLE; BRONCHOSPASM; CANADA; COUGHING; DIARRHEA; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG SAFETY; ENCEPHALITIS; FEVER; GRAM NEGATIVE SEPSIS; HEMATOCHEZIA; HUMAN; INFANT; INTUSSUSCEPTION; IRRITABILITY; MENINGITIS; MUCOCUTANEOUS LYMPH NODE SYNDROME; MYOCARDITIS; OTITIS MEDIA; PRACTICE GUIDELINE; RHINOPHARYNGITIS; ROTAVIRUS INFECTION; SEIZURE; SIDE EFFECT; SUDDEN INFANT DEATH SYNDROME; TREATMENT INDICATION; VACCINATION; VOMITING;

EID: 78349278425     PISSN: 12057088     EISSN: None     Source Type: Journal    
DOI: 10.1093/pch/15.8.519     Document Type: Article

References (32)

1. Butz AM, Fosarelli P, Dick J, Cusack T, Yolken R. Prevalence of rotavirus on high-risk fomites in day-care facilities. Pediatrics 1993;92:202-5. (Pubitemid 23226832)
2. Rivest P, Proulx M, Lonergan G, Lebel MH, Bédard L. Hospitalizations for gastroenteritis: The role of rotavirus. Vaccine 2004;22:2013-7
3. Sénécal M, Brisson M, Lebel MH, et al; MIRAGE study group. Severity, Healthcare Resource Use and Work Loss Related to Rotavirus-Associated Gastroenteritis: A Prospective Study in Community Practice. 7th Canadian Immunization Conference. Winnipeg, December 3 to 6, 2006.
4. Rodriguez WJ, Kim HW, Brandt CD, et al. Longitudinal study of rotavirus infection and gastroenteritis in families served by a pediatric medical practice: Clinical and epidemiologic observations. Pediatr Infect Dis J 1987;6:170-6.
5. Velázquez FR, Matson DO, Calva JJ, et al. Rotavirus infections in infants as protection against subsequent infections. N Engl J Med 1996;335:1022-8.
6. Jacobs P, Shane L, Fassbender K, Wang, Moineddin R, Ford-Jones E. Economic analysis of rotavirus-associated diarrhea in the metropolitan Toronto and Peel regions of Ontario. Can J Infect Dis 2002;13:167-74. (Pubitemid 34855525)
7. Buigues RP, Duval B, Rochette L, et al. Hospitalizations for diarrhea in Quebec children from 1985 to 1998: Estimates of rotavirus-associated diarrhea. Can J Infect Dis 2002;13:239-44.
8. Ford-Jones EL, Wang E, Petric M, Corey P, Moineddin R, Fearon M. Hospitalization for community-acquired, rotavirus-associated diarrhea: A prospective, longitudinal, population-based study during the seasonal outbreak. The Greater Toronto Area/Peel Region PRESI Study Group. Pediatric Rotavirus Epidemiology Study for Immunization. Arch Pediatr Adolesc Med 2000;154:578-85.
9. Ford-Jones EL, Wang E, Petric M, Corey P, Moineddin R, Fearon M. Rotavirus-associated diarrhea in outpatient settings and child care centers. The Greater Toronto Area/Peel Region PRESI Study Group. Pediatric Rotavirus Epidemiology Study for Immunization. Arch Pediatr Adolesc Med 2000;154:586-93.
10. Senecal M, Quach C. Brisson M. The burden of rotavirus-associated gastroenteritis in young Canadian children: A cohort model. Canadian Public Health Association 97th Annual Conference. Vancouver, May 30, 2006.
11. Le Saux N, Bettinger JA, Halperin SA, Vaudry W, Scheifele DW. Substantial morbidity for hospitalized children with community-acquired rotavirus infections: 2005-2007 IMPACT surveillance in Canadian hospitals. Pediatr Infect Dis J 2010;29:879-82.
12. Glass RI, Bresee JS, Parashar UD, Jiang B, Gentsch J. The future of rotavirus vaccines: A major setback leads to new opportunities. Lancet 2004;363:1547-50. (Pubitemid 38596836)
13. Malek MA, Curns AT, Holman RC, et al. Diarrhea- and rotavirus-associated hospitalizations among children less than 5 years of age: United States, 1997 and 2000. Pediatrics 2006;117:1887-92.
14. Dennehy PH, Cortese MM, Bégué RE, et al. A case-control study to determine risk factors for hospitalization for rotavirus gastroenteritis in U.S. children. Pediatr Infect Dis J 2006;25:1123-31.
15. Liakopoulou E, Mutton K, Carrington D, et al. Rotavirus as a significant cause of prolonged diarrhoeal illness and morbidity following allogeneic bone marrow transplantation. Bone Marrow Transplant 2005;36:691-4. (Pubitemid 41518711)
16. Rayani A, Bode U, Habas E, et al. Rotavirus infections in paediatric oncology patients: A matched-pairs analysis. Scand J Gastroenterol 2007;42:81-7. (Pubitemid 46033050)
17. Glass RI, Parashar UD, Bresee JS, et al. Rotavirus vaccines: Current prospects and future challenges. Lancet 2006;368:323-32.
18. World Health Organization. Global Advisory Committee on Vaccine Safety, 6-7 June 2006. Wkly Epidemiol Rec 2006;81:273-8.
19. Grimwood K, Buttery JP. Clinical update: Rotavirus gastroenteritis and its prevention. Lancet 2007;370:302-4. (Pubitemid 47094981)
20. Vesikari T, Matson DO, Dennehy P, et al; Rotavirus Efficacy and Safety Trial (REST) Study Team. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 2006;354:23-33.
21. Ruiz-Palacios GM, Perez-Schael I, Velazquez FR, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 2006;354:11-22. (Pubitemid 43048947)
22. Haber P, Patel M, Izurieta HS, et al. Postlicensure monitoring of intussusception after RotaTeq vaccination in the United States, February 1, 2006, to September 25, 2007. Pediatrics 2008;121:1206-12.
23. Vesikari T, Karvonen A, Prymula R, et al. Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: Randomised, double-blind controlled study. Lancet 2007;370:1757-63. (Pubitemid 350137490)
24. American Academy of Pediatrics, Committee on Infectious Disease. Prevention of rotavirus disease: Updated guidelines for use of rotavirus vaccine. Pediatrics 2009;123:1412-20.
25. Centers for Disease Control and Prevention. Delayed onset and diminished magnitude of rotavirus activity - United States, November 2007 - May 2008. MMWR Morb Mortal Wkly Rep 2008;57:697-700.
26. Cortese MM, Parashar UD; Centers for Disease Control and Prevention. Prevention of rotavirus gastroenteritis among infants and children: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2009;58(RR-2):1-25.
27. Centers for Disease Control and Prevention. Postmarketing monitoring of intussusception after RotaTeq vaccination - United States, February 1, 2006 - February 15, 2007. MMWR Morb Mortal Wkly Rep 2007;56:218-22.
28. Bines JE, Kohl KS, Forster J, et al; Brighton Collaboration Intussusception Working Group. Acute intussusception in infants and children as an adverse event following immunization: Case definition and guidelines of data collection, analysis, and presentation. Vaccine 2004;22:569-74.
29. Simonsen L, Viboud C, Elixhauser A, Taylor RJ, Kapikian AZ. More on RotaShield and intussusception: The role of age at the time of vaccination. J Infect Dis 2005;192:S36-43.
30. Rothman KJ, Young-Xu Y, Arellano F. Age dependence of the relation between reassortant rotavirus vaccine (RotaShield) and intussusception. J Infect Dis 2006;193:898.
31. National Advisory Committee on Immunization. Statement on the recommended use of pentavalent human-bovine reassortant rotavirus vaccine. An Advisory Committee Statement (ACS). Can Commun Dis Rep 2008;34:1-33.
32. Canadian Task Force on Preventive Health Care. 〈www. canadiantaskforce.ca/recommendations/2003-04-eng.html〉